Focus on Covid-19 does not distract the FDA
Non-Covid-19 medical device approvals tick up alongside the agency’s pandemic efforts.
Astounding success greets newly public device makers
2020 was a bountiful year for medtechs making their public debut, with one group, Inari Medical, more than quadrupling in value.
Medtechs rake in the venture cash
In terms of private investments, 2020 was the year of the liquid biopsy.
Medtech deal-making stands firm in difficult times
It takes more than a pandemic to stop medical device companies merging.
